SCHEMBL27762008

SCHEMBL27762008

CC(C(=O)C(C)c1ccccc1N1CCN(C)CC1)c1ccccc1N1CCN(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.49
MAPK1 P28482 4/20 0.48
LMNA P02545 2/20 0.48
KMT2A Q03164 2/20 0.48
EGFR P00533 1/20 0.48
MAPT P10636 1/20 0.48
DRD2 P14416 6/20 0.46
HTR1A P08908 4/20 0.46
DRD3 P35462 3/20 0.46
POLB P06746 1/20 0.44
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13006367 0.81 ADRA2C (0.56) ADRA2CMAPK1LMNAKMT2AEGFR
SCHEMBL20376817 0.79 ADRA2C (0.51) ADRA2CMAPK1LMNAKMT2AEGFR
SCHEMBL27741258 0.79 POLB (0.54) LMNAKMT2AMAPTPOLBMEN1
SCHEMBL27762010 0.77 ADRA2C (0.49) ADRA2CMAPK1LMNAKMT2AEGFR
SCHEMBL27760541 0.76 ADRA2C (0.55) ADRA2CMAPK1LMNAKMT2AEGFR
SCHEMBL2113196 0.75 ADRA2C (0.50) ADRA2CMAPK1LMNAKMT2AEGFR
SCHEMBL11288764 0.75 KCNQ2 (0.54) KMT2AMAPTGAANPSR1
SCHEMBL11275499 0.74 KCNQ2 (0.52) KMT2AMAPTMEN1GAANPSR1
SCHEMBL27741260 0.74 SMN1; SMN2 (0.48) DRD3POLBHDAC3HDAC4HDAC1
SCHEMBL24227168 0.73 ADRA2C (0.47) ADRA2CMAPK1LMNAKMT2AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101448802-B Acrylamide derivative as histone deacetylase inhibitors for cancer treatment DAC SRL 2012-11-07 CN disclosed
CN-101448802-A N-hydroxy-3-(4-{3-phenyl-S-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer DAC SRL (IT) 2009-06-03 CN disclosed